The Phase 1 human clinical trials of Hyderabad-based vaccine maker Bharat Biotech’s intranasal Covid-19 vaccine, codenamed BBV154, have commenced at some of the selected sites that include Hyderabad and Nagpur.
Category: Startups
WashU Celebration of Inventors 2021
Join the WashU Office of Technology Management for this annual event honoring: 2020 Patent Awards New Faculty Startups — Caeli Vascular, Capella Imaging, Coordinate Medical Systems, DeepSight Technology, HSpeQ, Integro Theranostics & Percayai National Academy of Inventors Fellows & Senior Member — Randall Bateman, Richard Cote, Michael Diamond & Scott Hultgren Thursday, April 15, 20214:30 […]
Wugen Announces Exclusive License Agreement for their Memory Natural Killer (NK) Cell-based Therapy Program with Washington University in St. Louis (Links to an external site)
Wugen Inc., a biotechnology company developing novel, universal allogeneic cellular therapies, today announced that it has entered into an exclusive license agreement with Washington University in St. Louis, one of the world’s leading research institutions, for the development of Wugen’s Memory Natural Killer (NK) Cell program.
C2N Diagnostics has brought its Alzheimer’s blood test to market. Now it wants to expand in St. Louis and beyond. (Links to an external site)
St. Louis-based C2N Diagnostics has developed what it says is the first blood test to help diagnose Alzheimer’s disease. Now it has plans to take the technology global.
Encodia closes $75M Series C Financing led by Northpond Ventures and Deerfield Management (Links to an external site)
Encodia is a WashU faculty startup. The company is developing revolutionary tools for large-scale protein analysis to enable breakthrough insights into biology and the prevention, diagnosis, and treatment of disease.
Combo of blood tests could offer more accurate Alzheimer’s diagnostics, researchers say (Links to an external site)
Drs. Randall Bateman and David Holtzman, founders of C2N and neurology professors at Washington University School of Medicine in St. Louis, recently explained their amyloid blood test to Fox News.
St. Louis-based Precision Virologics and India’s Biotech leader Bharat Biotech obtain rights to intranasal COVID-19 vaccine technology (Links to an external site)
Biotech startup Precision Virologics, which develops adenovirus-based vaccines in St. Louis, and Bharat Biotech, a manufacturing giant of vaccines, jointly obtained rights from Washington University School of Medicine in St. Louis for a novel chimp-adenovirus vaccine for COVID-19. Precision Virologics has optioned rights for USA, Europe, and Japan. Bharat has obtained a license for all other markets.
Equalize — 2020 and Beyond (Links to an external site)
With this article, we wanted to articulate the need and history of Equalize 2020, the experiences of those involved, and our thoughts on where to take this effort next.
New WashU Faculty Startups
New Faculty Startups (FY July 1, 2019 – June 30, 2020) Caeli VascularCapella ImagingCoordinate Medical SystemsDeepSight TechnologyHSpeQIntegro TheranosticsPercayai The new startups will be introduced at the annual WashU Celebration of Inventors on April 15, 2021 via Zoom.